Demand for proton beam therapy is unlikely to be satisfied by all of the new provision planned for the UK, according to Proton Partners International chief medical officer Professor Karol Sikora. Proton beam therapy has fewer side effects than other more conventional forms of cancer treatment but is not suitable for all patients. However, Speaking…
Home LaingBuisson Newsletter Archives Healthcare Markets UK will need more proton beam therapy provision